Synapse Technologies

Synapse Technologies Overview

Founded 1992
Status Acquired/​Merged
Latest Deal Type M&A
Latest Deal Amount $15.3M
Latest Deal Amount

Synapse Technologies General Information


Developer of proprietary technology to deliver therapeutic enzymes and other drugs. The company focuses on discovery, development and commercialization of transport systems for therapeutic drug delivery across the blood brain barrier and new drug targets in neurodegenerative disease.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Primary Office
  • 6660 NorthWest Marine Drive
  • Vancouver, British Columbia B6T 1Z4
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synapse Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Mar-2002 $15.3M 000 000.00 Completed Clinical Trials - General
1. Later Stage VC 12-Jan-2000 000 000 Completed Startup

Synapse Technologies Executive Team (1)

Name Title Board Seat Contact Info
Z Ruttonsha Chief Executive Officer & President

Synapse Technologies Former Investors (8)

To view Synapse Technologies‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BMO Financial Group Lender/Debt Provider Minority 000 0000 000000 0
Business Development Bank of Canada Growth/Expansion Minority 000 0000 000000 0
FutureFund Capital Venture Capital Minority 000 0000 000000 0
GrowthWorks Venture Capital Minority 000 0000 000000 0
MDS Ventures Pacific Minority 000 0000 000000 0

Ready to get started?

Request a free trial